Verrica Pharmaceuticals Stock Market Value
| VRCA Stock | USD 1.28 0.04 3.23% |
| Symbol | Verrica |
Verrica Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 0.198 | Quarterly Revenue Growth 27.445 | Return On Assets (0.71) | Return On Equity (20.60) |
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Verrica Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verrica Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verrica Pharmaceuticals.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Verrica Pharmaceuticals on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Verrica Pharmaceuticals or generate 0.0% return on investment in Verrica Pharmaceuticals over 30 days. Verrica Pharmaceuticals is related to or competes with Crinetics Pharmaceuticals, Enanta Pharmaceuticals, Amicus Therapeutics, Connect Biopharma, Ligand Pharmaceuticals, Passage Bio, and Oric Pharmaceuticals. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with... More
Verrica Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verrica Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verrica Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 74.69 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 12.12 |
Verrica Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verrica Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verrica Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Verrica Pharmaceuticals historical prices to predict the future Verrica Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (2.01) | |||
| Treynor Ratio | (0.61) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verrica Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Verrica Pharmaceuticals Backtested Returns
Verrica Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.033, which indicates the firm had a -0.033% return per unit of risk over the last 3 months. Verrica Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verrica Pharmaceuticals' Variance of 91.31, coefficient of variation of (2,374), and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide. The entity has a beta of 0.68, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Verrica Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Verrica Pharmaceuticals is expected to be smaller as well. At this point, Verrica Pharmaceuticals has a negative expected return of -0.32%. Please make sure to validate Verrica Pharmaceuticals' kurtosis, as well as the relationship between the rate of daily change and market facilitation index , to decide if Verrica Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.4 |
Poor reverse predictability
Verrica Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Verrica Pharmaceuticals time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verrica Pharmaceuticals price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Verrica Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Verrica Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Verrica Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Verrica Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Verrica Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Verrica Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Verrica Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Verrica Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Verrica Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Verrica Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Verrica Pharmaceuticals Lagged Returns
When evaluating Verrica Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Verrica Pharmaceuticals stock have on its future price. Verrica Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Verrica Pharmaceuticals autocorrelation shows the relationship between Verrica Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Verrica Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Verrica Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verrica Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verrica Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verrica Pharmaceuticals Stock:Check out Verrica Pharmaceuticals Correlation, Verrica Pharmaceuticals Volatility and Verrica Pharmaceuticals Alpha and Beta module to complement your research on Verrica Pharmaceuticals. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Verrica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.